Tumour necrosis factor-α inhibitor use in patients with psoriasis with organ transplantation

British Journal of Dermatology

Volumn 169, Issue 2, 2013, Pages 481-483

  Mansouri, B ^a   Patel, M ^b   Menter, A ^b  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; ETANERCEPT; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ABSENCE OF SIDE EFFECTS; ADULT; BACTEREMIA; BODY SURFACE; CANDIDIASIS; CASE REPORT; COLITIS; CRYPTOSPORIDIOSIS; DRUG SAFETY; ENTERITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LETTER; LIVER TRANSPLANTATION; LUPUS LIKE SYNDROME; MALE; ORGAN TRANSPLANTATION; PNEUMONIA; PRIORITY JOURNAL; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; PYELONEPHRITIS; SEPSIS;

BIOLOGICAL PRODUCTS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PSORIASIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84881571049     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12326     Document Type: Letter

References (11)

1. Nestle FO, Kaplan DH, Barker J,. Psoriasis. N Engl J Med 2009; 361: 496-509.
2. Ryan C, Abramson A, Patel M, Menter A,. Current investigational drugs in psoriasis. Expert Opin Investig Drugs 2012; 21: 473-87.
3. Brokalaki EI, Voshege N, Witzke O, et al,. Treatment of severe psoriasis with etanercept in a pancreas-kidney transplant recipient. Transplant Proc 2012; 44: 2776-7.
4. Collazo MH, Gonzalez JR, Torres EA,. Etanercept therapy for psoriasis in a patient with concomitant hepatitis C and liver transplant. P R Health Sci J 2008; 27: 346-7.
5. El-Nachef N, Terdiman J, Mahadevan U,. Anti-tumor necrosis factor therapy for inflammatory bowel disease in the setting of immunosuppression for solid organ transplantation. Am J Gastroenterol 2010; 105: 1210-11.
6. Hoover WD,. Etanercept therapy for severe plaque psoriasis in a patient who underwent a liver transplant. Cutis 2007; 80: 211-14.
7. Lal S, Steinhart AH,. Infliximab for ulcerative colitis following liver transplantation. Eur J Gastroenterol Hepatol 2007; 19: 277-80.
8. Mohabbat AB, Sandborn WJ, Loftus EV Jr, et al,. Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients. Aliment Pharmacol Ther 2012; 36: 569-74.
9. Page AV, Liles WC,. Tumor necrosis factor-alpha inhibitor-induced lupus-like syndrome presenting as fever of unknown origin in a liver transplant recipient: case report and concise review of the literature. Transplant Proc 2008; 40: 1768-70.
10. Sandhu A, Alameel T, Dale CH, et al,. The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series. Aliment Pharmacol Ther 2012; 36: 159-65.
11. Temme J, Koziolek M, Bramlage C, et al,. Infliximab as therapeutic option in steroid-refractory ulcerative colitis after kidney transplantation: case report. Transplant Proc 2010; 42: 3880-2.